世界の慢性腎臓病（CKD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Kidney Disease (CKD) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1317 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、慢性腎臓病（CKD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他）、用途別市場規模（病院、専門クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性腎臓病（CKD）の市場動向 ・企業の競争状況、市場シェア ・慢性腎臓病（CKD）の種類別市場規模（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他） ・慢性腎臓病（CKD）の用途別市場規模（病院、専門クリニック） ・慢性腎臓病（CKD）の北米市場規模2016-2027（アメリカ、カナダ） ・慢性腎臓病（CKD）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性腎臓病（CKD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性腎臓病（CKD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性腎臓病（CKD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Allergan、Amgen、AstraZeneca、Roche、FibroGen、GlaxoSmithKline、Johnson & Johnson、Keryx、Kissei、Pfizer、Sanofi、Teva） ・結論

Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market
The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Kidney Disease (CKD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Kidney Disease (CKD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Kidney Disease (CKD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Kidney Disease (CKD) market.

Global Chronic Kidney Disease (CKD) Scope and Market Size
Chronic Kidney Disease (CKD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease (CKD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others

Segment by Application
Hospitals
Specialty Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
AstraZeneca
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blockers
1.2.4 Beta Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Kidney Disease (CKD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Kidney Disease (CKD) Market Perspective (2016-2027)
2.2 Chronic Kidney Disease (CKD) Growth Trends by Regions
2.2.1 Chronic Kidney Disease (CKD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Kidney Disease (CKD) Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Kidney Disease (CKD) Industry Dynamic
2.3.1 Chronic Kidney Disease (CKD) Market Trends
2.3.2 Chronic Kidney Disease (CKD) Market Drivers
2.3.3 Chronic Kidney Disease (CKD) Market Challenges
2.3.4 Chronic Kidney Disease (CKD) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue
3.1.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue (2016-2021)
3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Kidney Disease (CKD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Revenue
3.4 Global Chronic Kidney Disease (CKD) Market Concentration Ratio
3.4.1 Global Chronic Kidney Disease (CKD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Revenue in 2020
3.5 Chronic Kidney Disease (CKD) Key Players Head office and Area Served
3.6 Key Players Chronic Kidney Disease (CKD) Product Solution and Service
3.7 Date of Enter into Chronic Kidney Disease (CKD) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Kidney Disease (CKD) Breakdown Data by Type
4.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2016-2021)
4.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2022-2027)

5 Chronic Kidney Disease (CKD) Breakdown Data by Application
5.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Application (2016-2021)
5.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Kidney Disease (CKD) Market Size (2016-2027)
6.2 North America Chronic Kidney Disease (CKD) Market Size by Type
6.2.1 North America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
6.2.2 North America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
6.2.3 North America Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
6.3 North America Chronic Kidney Disease (CKD) Market Size by Application
6.3.1 North America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
6.3.2 North America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
6.3.3 North America Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
6.4 North America Chronic Kidney Disease (CKD) Market Size by Country
6.4.1 North America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
6.4.2 North America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Market Size (2016-2027)
7.2 Europe Chronic Kidney Disease (CKD) Market Size by Type
7.2.1 Europe Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
7.2.2 Europe Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
7.2.3 Europe Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
7.3 Europe Chronic Kidney Disease (CKD) Market Size by Application
7.3.1 Europe Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
7.3.2 Europe Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
7.3.3 Europe Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
7.4 Europe Chronic Kidney Disease (CKD) Market Size by Country
7.4.1 Europe Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
7.4.2 Europe Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size (2016-2027)
8.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type
8.2.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application
8.3.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region
8.4.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Kidney Disease (CKD) Market Size (2016-2027)
9.2 Latin America Chronic Kidney Disease (CKD) Market Size by Type
9.2.1 Latin America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
9.3 Latin America Chronic Kidney Disease (CKD) Market Size by Application
9.3.1 Latin America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
9.4 Latin America Chronic Kidney Disease (CKD) Market Size by Country
9.4.1 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size (2016-2027)
10.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type
10.2.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application
10.3.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country
10.4.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction
11.1.4 AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Chronic Kidney Disease (CKD) Introduction
11.2.4 Allergan Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Chronic Kidney Disease (CKD) Introduction
11.3.4 Amgen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction
11.4.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Chronic Kidney Disease (CKD) Introduction
11.5.4 Roche Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.5.5 Roche Recent Development
11.6 FibroGen
11.6.1 FibroGen Company Details
11.6.2 FibroGen Business Overview
11.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction
11.6.4 FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.6.5 FibroGen Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction
11.7.4 GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Keryx
11.9.1 Keryx Company Details
11.9.2 Keryx Business Overview
11.9.3 Keryx Chronic Kidney Disease (CKD) Introduction
11.9.4 Keryx Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.9.5 Keryx Recent Development
11.10 Kissei
11.10.1 Kissei Company Details
11.10.2 Kissei Business Overview
11.10.3 Kissei Chronic Kidney Disease (CKD) Introduction
11.10.4 Kissei Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.10.5 Kissei Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction
11.11.4 Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction
11.12.4 Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Teva
11.13.1 Teva Company Details
11.13.2 Teva Business Overview
11.13.3 Teva Chronic Kidney Disease (CKD) Introduction
11.13.4 Teva Revenue in Chronic Kidney Disease (CKD) Business (2016-2021)
11.13.5 Teva Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ACE Inhibitors
Table 3. Key Players of Calcium Channel Blockers
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Others
Table 6. Global Chronic Kidney Disease (CKD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Kidney Disease (CKD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chronic Kidney Disease (CKD) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chronic Kidney Disease (CKD) Market Share by Regions (2016-2021)
Table 10. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chronic Kidney Disease (CKD) Market Share by Regions (2022-2027)
Table 12. Chronic Kidney Disease (CKD) Market Trends
Table 13. Chronic Kidney Disease (CKD) Market Drivers
Table 14. Chronic Kidney Disease (CKD) Market Challenges
Table 15. Chronic Kidney Disease (CKD) Market Restraints
Table 16. Global Chronic Kidney Disease (CKD) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chronic Kidney Disease (CKD) Market Share by Players (2016-2021)
Table 18. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) as of 2020)
Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Kidney Disease (CKD) Product Solution and Service
Table 23. Date of Enter into Chronic Kidney Disease (CKD) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2016-2021)
Table 27. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chronic Kidney Disease (CKD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2016-2021)
Table 31. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Chronic Kidney Disease (CKD) Product
Table 66. AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Allergan Company Details
Table 69. Allergan Business Overview
Table 70. Allergan Chronic Kidney Disease (CKD) Product
Table 71. Allergan Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 72. Allergan Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen Chronic Kidney Disease (CKD) Product
Table 76. Amgen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Chronic Kidney Disease (CKD) Product
Table 81. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Chronic Kidney Disease (CKD) Product
Table 86. Roche Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. FibroGen Company Details
Table 89. FibroGen Business Overview
Table 90. FibroGen Chronic Kidney Disease (CKD) Product
Table 91. FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 92. FibroGen Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Chronic Kidney Disease (CKD) Product
Table 96. GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. Johnson & Johnson Company Details
Table 99. Johnson & Johnson Business Overview
Table 100. Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 101. Johnson & Johnson Recent Development
Table 102. Keryx Company Details
Table 103. Keryx Business Overview
Table 104. Keryx Chronic Kidney Disease (CKD) Product
Table 105. Keryx Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 106. Keryx Recent Development
Table 107. Kissei Company Details
Table 108. Kissei Business Overview
Table 109. Kissei Chronic Kidney Disease (CKD) Product
Table 110. Kissei Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 111. Kissei Recent Development
Table 112. Pfizer Company Details
Table 113. Pfizer Business Overview
Table 114. Pfizer Chronic Kidney Disease (CKD) Product
Table 115. Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 116. Pfizer Recent Development
Table 117. Sanofi Company Details
Table 118. Sanofi Business Overview
Table 119. Sanofi Chronic Kidney Disease (CKD) Product
Table 120. Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 121. Sanofi Recent Development
Table 122. Teva Company Details
Table 123. Teva Business Overview
Table 124. Teva Chronic Kidney Disease (CKD) Product
Table 125. Teva Revenue in Chronic Kidney Disease (CKD) Business (2016-2021) & (US$ Million)
Table 126. Teva Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Kidney Disease (CKD) Market Share by Type: 2020 VS 2027
Figure 2. ACE Inhibitors Features
Figure 3. Calcium Channel Blockers Features
Figure 4. Beta Blockers Features
Figure 5. Others Features
Figure 6. Global Chronic Kidney Disease (CKD) Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Chronic Kidney Disease (CKD) Report Years Considered
Figure 10. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Kidney Disease (CKD) Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Kidney Disease (CKD) Market Share by Regions (2022-2027)
Figure 14. Global Chronic Kidney Disease (CKD) Market Share by Players in 2020
Figure 15. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2020
Figure 17. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
Figure 21. North America Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
Figure 22. North America Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
Figure 23. United States Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
Figure 27. Europe Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
Figure 28. Europe Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
Figure 29. Germany Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Region (2016-2027)
Figure 39. China Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Kidney Disease (CKD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 59. Allergan Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 63. FibroGen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 66. Keryx Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 67. Kissei Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 70. Teva Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---